Should You Hold Kiromic Biopharma Inc (KRBP) in Biotechnology Industry?

Monday, January 30, 2023 01:08 PM | InvestorsObserver Analysts

Mentioned in this article

Should You Hold Kiromic Biopharma Inc (KRBP) in Biotechnology Industry?

A rating of 2 puts Kiromic Biopharma Inc (KRBP) near the bottom of the Biotechnology industry according to InvestorsObserver. Kiromic Biopharma Inc's score of 2 means it scores higher than 2% of stocks in the industry. Kiromic Biopharma Inc also received an overall rating of 2, putting it above 2% of all stocks. Biotechnology is ranked 40 out of the 148 industries.

KRBP has an Overall Score of 2. Find out what this means to you and get the rest of the rankings on KRBP!

See Full KRBP Report

What do These Ratings Mean?

Searching for the best stocks to invest in can be difficult. There are thousands of options and it can be confusing on what actually constitutes a great value. InvestorsObserver allows you to choose from eight unique metrics to view the top industries and the best performing stocks in that industry. A score of 2 would rank higher than 2 percent of all stocks. These scores are not only easy to understand, but it is easy to compare stocks to each other. You can find the best stock in an industry, or look for the sector that has the highest average score. The overall score is a combination of technical and fundamental factors that serves as a good starting point when analyzing a stock. Traders and investors with different goals may have different goals and will want to consider other factors than just the headline number before making any investment decisions.

What's Happening With Kiromic Biopharma Inc Stock Today?

Kiromic Biopharma Inc (KRBP) stock is unmoved 2.27% while the S&P 500 is down -0.97% as of 1:08 PM on Monday, Jan 30. KRBP is unmoved $0.00 from the previous closing price of $0.20 on volume of 3,071,944 shares. Over the past year the S&P 500 has fallen -10.73% while KRBP is down -81.82%. KRBP lost -$2.46 per share the over the last 12 months. Click Here to get the full Stock Report for Kiromic Biopharma Inc stock.